Found 83 matching trials
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection PHASE3 This study was to assess whether sofosbuvir in combination with ribavirin (...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Neutrino Regimen for Treatment-experienced HCV GT1 Patients PHASE4 This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Show More Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Learn More & Join Trial
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype PHASE3 The purpose of this study is to evaluate if a 12-week total regimen of tela...
Show More Location
Multiple Locations
Learn More & Join Trial
A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment PHASE3 The purpose of this study is to determine the safety, efficacy and tolerabi...
Show More Location
Multiple Locations
Learn More & Join Trial
Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy PHASE4 The purpose of this study is to evaluate the impact of a physician directed...
Show More Location
California Liver Institute
Learn More & Join Trial
An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation PHASE3 The purpose of this study is to evaluate the effectiveness of telaprevir in...
Show More Location
Multiple Locations
Learn More & Join Trial
Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels PHASE4 Patients with chronic hepatitis C with persistently normal alanine aminotra...
Show More Location
Università degli Studi di Torino - Azienda Ospedaliera San Giovanni Battista di Torino, Molinette,
Learn More & Join Trial
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 PHASE4 The study aims to study the outcome of pharmacokinetics-adjusted dose ribav...
Show More Location
King Faisal Specialist Hospital & Research Centre
Learn More & Join Trial
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients PHASE2 To assess efficacy of telaprevir, pegylated interferon alfa-2a (Peg-IFN-alf...
Show More Learn More & Join Trial
Directly Observed Hepatitis C Treatment in Methadone Clinics NA Drug users account for a disproportionately large burden of hepatitis C vir...
Show More Location
Albert Einstein College of Medicine Division of Substance Abuse
Learn More & Join Trial